No one really expected the pharmaceutical industry to lie down and take it when Congress authorized Medicare to start negotiating prices of the prescription drugs it buys for enrollees.
By that standard, the federal lawsuit filed June 6 by the big drug manufacturer Merck falls into the "dog bites man" category of non-news.
So, too, does a nearly identical lawsuit filed June 9 by the U.S. Chamber of Commerce. And also the threats by other drug companies to file their own lawsuits.
